Pfizer teams up with University of California for drug discovery

August 9, 2011
Research and Development, Sales and Marketing Pfizer, academic research

Pfizer has signed a deal with the University of California to help expand its drug discovery and development programme. The …

Investment firm adds Roche facility to growing portfolio

August 9, 2011
Manufacturing and Production Colarado, International Chemical Investors, Roche, pharma manufacturing news

International Chemical Investors Group has snapped up another manufacturing facility, this time agreeing to buy a plant owned by Roche …

SkyePharma leases manufacturing business to CMO

August 9, 2011
Manufacturing and Production Aenova, Skyepharma, pharma manufacturing news

German contract manufacturer Aenova is to lease a manufacturing unit near Lyon, France, from UK drugmaker SkyePharma. Aenova has taken …

Lonza profits slide as exchange rates bite

August 9, 2011
Manufacturing and Production CMO, Lonza

A strong Swiss franc has pegged back first-half profits at fine chemical and contract manufacturer Lonza, although the company said …

Pradaxa approved for stroke prevention in Europe

August 9, 2011
Sales and Marketing Pradaxa, atrial fibrillation, direct thrombin inhibitor

Boehringer Ingelheim’s Pradaxa has become the first drug in 50 years to be approved in Europe for stroke prevention in …

Gilead buys manufacturing plant from Genentech

August 9, 2011
Manufacturing and Production Genentech, Gilead, biologics

Roche unit Genentech has agreed to sell a clinical manufacturing plant in California to Gilead Sciences. The 70,000 sq. ft. …

Takeda and Amylin stop obesity trial

August 8, 2011
Research and Development, Sales and Marketing Amylin, Takeda

Takeda and Amylin have decided to halt further studies of its combination treatment for obesity, due to ‘evolving dynamics’ within …

Pfizer building

Biotica becomes new victim of Pfizer’s R&D downsizing

August 8, 2011
Research and Development, Sales and Marketing

Pfizer has pulled out of a $195 million deal with UK firm Biotica, as it continues to downsize its global …

Meet Wainwright Associates at the TOPRA Symposium and CPhl worldwide

August 7, 2011
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Wainwright Associates

Wainwright Associates is an independent company offering consultancy services to the pharmaceutical, medical device and healthcare industry in Product Development, …

Dissent over patient involvement reforms

August 5, 2011
Medical Communications HealthWatch, NHS, patient involvement

The first 75 ‘pathfinders’ have been named in Local HealthWatch, the patient representative organisations due to replace the current local …

Gilenya

Gilenya rejected by NICE

August 5, 2011
Medical Communications, Sales and Marketing MS, NICE, Novartis, gilenya

NICE has not recommended Novartis’ multiple sclerosis drug Gilenya because of its cost and ‘uncertainties over its clinical effectiveness’. Gilenya …

First personalised asthma drug shows promise

August 4, 2011
Roche, asthma, personalised medicine

Roche’s personalised asthma drug lebrikizumab has met its primary end point in a phase II trial. Lebrikizumab increased the level …

NHS must personalise services for long-term conditions

August 3, 2011
Sales and Marketing NHS, long term conditions

The government is highlighting a scheme in West Yorkshire as providing a way forward for reducing the cost burden on …

Mergers and spending cuts damaging drug research

August 3, 2011
Research and Development, Sales and Marketing LaMattina, Pfizer, research productivity

Big pharma’s policy of mergers and swingeing cuts is having a devastating effect on drug research, says a former Pfizer …

SHL to Speak and Exhibit at the World Drug Delivery Congress 2011

August 3, 2011
Manufacturing and Production auto injector, autoinjector, drug delivery, imapac, shl group

With the increasing number of biologics coming to market, the demand for drug delivery solutions such as auto injectors has …

Pfizer HQ

Pfizer looks to spin off animal health and nutrition

August 2, 2011
Sales and Marketing Pfizer, Q2, animal health, divestment, nutrition

Pfizer looks set to spin-off or sell its animal health and nutrition business units in order to focus on human …

Fujifilm plans generic venture with Dr. Reddy’s

August 2, 2011
Manufacturing and Production Dr Reddy's, Fujifilm

Japanese photography and imaging company Fujifilm has taken another step into the healthcare sector with a new joint venture with …

Actelion’s MS candidate shows promise

August 2, 2011
Research and Development Actelion, MS

Actelion’s prospective multiple sclerosis pill ponesimod has cheered the company by meeting its primary endpoint in a phase IIb trial. …

US debt deal could hit pharma

August 2, 2011
Sales and Marketing Obama, PhRMA, US, healthcare reform

The deal to raise America’s debt ceiling could have long-term consequences for the US pharma industry. The tense stand-off between …

Teva’s MS treatment disappoints

August 2, 2011
Research and Development, Sales and Marketing Laquinimod, MS, Teva

Teva and Active Biotech’s oral MS drug laquinimod has failed to meet its primary endpoint in a phase III trial. …

The Gateway to Local Adoption Series

Latest content